Interesting, page-5265

Firstly let me state that I have held this stock for 3 years and see myself as a future long term holder and a strong believer in the product. Over the past 3 years I have see what some may view as questionable decisions from Management/BOD in regards to capital raising, strategic timing and shareholder communication. Today as the SP heads to sub 6c I am struggling to understand why management/BOD cannot clear the air regarding the ‘multiple’ enrolments. Is the market perception now imbedded that ‘multiple’ is so few that it has to be hidden behind a wall of silence? It really isn’t the fact that the SP is dropping it is more the long term scepticism the market may have as we progress. Clear and concise information delivery during set target trials is in my view a key to establishing a high level of market credibility and a strong foundation for the SP when things don’t go by the book. I would welcome comments on what the downside of communication from the company is on actual participation numbers and the upside of not giving this detail gives the company.